Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer. - Nie H; Liao L; Zielinski RJ; Gomez JA; Basi AV; Seeley EH; Tan L; Bilecz AJ; Zhou W; Liu H; Wang C; Wu S; et al. (Cancer research, 2025)